The U.S. Food and Drug Administration will remove the "black box" warning labels on many hormone therapy drugs used for menopause and perimenopause symptoms -- a major turnaround that's likely to encourage more women to seek treatment. FDA Commissioner Dr. Marty Makary spoke exclusively to senior correspondent Norah O'Donnell.